Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G

Journal of Clinical Neuroscience

Volumn 16, Issue 4, 2009, Pages 549-553

  Gok, Beril ^a   Sciubba, Daniel M ^b   Okutan, Ozerk ^a   Beskonakli, Etem ^a   Palaoglu, Selcuk ^c   Erdamar, Husamettin ^d   Sargon, Mustafa F ^c  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c HACETTEPE UNIVERSITY   (Turkey)

^d BEYTEPE MILITARY HOSPITAL   (Turkey)

Author keywords

Immunoglobulin; Immunomodulation therapy; Myeloperoxidase; Neuroprotection; Spinal cord injury

Indexed keywords

BIOCHEMICAL MARKER; HUMAN ALBUMIN; IMMUNOGLOBULIN G; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASSO BEATTIE BRESNAHAN MOTOR SCALE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; ENZYME ACTIVITY; FEMALE; IMMUNOMODULATION; LAMINECTOMY; LIPID PEROXIDATION; MOTOR PERFORMANCE; MYELINATED NERVE; NEUROPROTECTION; NONHUMAN; NONMYELINATED NERVE; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SINGLE DRUG DOSE; SPINAL CORD INJURY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; LIPID PEROXIDATION; MALE; MICROSCOPY, ELECTRON, SCANNING; MYELIN SHEATH; NEUROLOGIC EXAMINATION; NEURONS; PEROXIDASE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; SPINAL CORD INJURIES; TIME FACTORS;

EID: 61449121949     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.04.024     Document Type: Article

References (21)

1. Hamada Y., Ikata T., Katoh S., et al. Involvement of an intracellular adhesion molecule dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats. J Neurochem 32 (1996) 192-194
2. Popovich P.G. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog. Brain Res 128 (2000) 43-58
3. Taoka Y., Okajima K., Uchiba M., et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79 (1997) 1177-1182
4. Yang L., Blumbergs P.C., Jones N.R., et al. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine 29 (2004) 966-971
5. Gok B., Okutan O., Beskonakli E., et al. Effect of immunomodulation with human interferon-beta on early functional recovery from experimental spinal cord injury. Spine 32 (2007) 873-880
6. Sharief M.K., Ingram D.A., Swash M., et al. I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome. Neurology 52 (1999) 1833-1838
7. Stangel M., Compston A., and Scolding N.J. Oligodendroglia are protected from antibodymediated complement injury by normal immunoglobulins ("IVIg"). J Neuroimmunol 103 (2000) 195-201
8. Stangel M., Joly E., Scolding N.J., et al. Normal polyclonal immunoglobulin (IVIg) inhibit microglial phagocytosis in vitro. J Neuroimmunol 106 (2000) 137-144
9. Warrington A.E., Asakura K., Bieber A.J., et al. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA 97 (2000) 6820-6825
10. Knoblach S.M., and Faden A.I. Administration of either anti-intercellular adhesion molecule-1 or a nonspecific control antibody improves recovery after traumatic brain injury in the rat. J Neurotrauma 19 (2002) 1039-1050
11. Lapointe B.M., Herx L.M., Gill V., et al. IVIg therapy in brain inflammation : etiology-dependent differential effects on leucocyte recruitment. Brain 127 (2004) 2649-2656
12. Allen AR. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA 1911;57:878-80.
13. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytic Biochem 95 (1979) 351-358
14. Basso D.M., Beattie M.S., and Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139 (1996) 244-256
15. Rivlin A.S., and Tator C.H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 10 (1978) 39-43
16. Sewell D.L., Nacewicz B., Liu F., et al. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5: a receptor antagonist. J Neuroimmunol 155 (2004) 55-63
17. Andersson U.G., Bjork L., Skansen-Saphir U., et al. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 79 (1993) 211-216
18. Aukrust P., Froland S.S., Liabakk N.B., et al. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood 84 (1994) 2136-2143
19. Leung D.Y., Cotran R.S., Kurt-Jones E., et al. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 2 (1989) 1298-1302
20. Jonas E., Dwenger A., and Jonas M. Chemiluminescence response and adherence of neutrophils to cultured endothelial cells - influence of immunoglobulinG. J Biolumin Chemilumin 10 (1995) 169-173
21. Xu C., Poirier B., Van Huyen J.P., et al. Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases. Am J Pathol 153 (1998) 1257-1266